Document is current

Development of new basal insulin peglispro (LY2605541) ends in a disappointing result

Crossref DOI link: https://doi.org/10.1007/s13340-016-0255-1

Published Online: 2016-01-29

Published Print: 2016-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy